Filing Details
- Accession Number:
- 0001384101-19-000108
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-08-14 16:15:40
- Reporting Period:
- 2019-08-12
- Accepted Time:
- 2019-08-14 16:15:40
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1384101 | Veracyte Inc. | VCYT | Services-Medical Laboratories (8071) | 205455398 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1769333 | C Giulia Kennedy | 6000 Shoreline Court Suite 300 South San Francisco CA 94080 | Chief Scientific & Med Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-08-12 | 8,243 | $10.45 | 56,575 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2019-08-12 | 1,667 | $8.86 | 58,242 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2019-08-12 | 5,000 | $6.45 | 63,242 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2019-08-12 | 1,563 | $5.43 | 64,805 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2019-08-12 | 7,083 | $9.05 | 71,888 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2019-08-12 | 4,406 | $5.98 | 76,294 | No | 4 | M | Direct | |
Common Stock | Disposition | 2019-08-12 | 28,257 | $25.38 | 48,037 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2019-08-13 | 4,640 | $10.45 | 52,677 | No | 4 | M | Direct | |
Common Stock | Disposition | 2019-08-13 | 4,640 | $25.45 | 48,037 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2019-08-12 | 8,243 | $0.00 | 8,243 | $10.45 |
Common Stock | Stock Option (right to buy) | Disposition | 2019-08-12 | 1,667 | $0.00 | 1,667 | $8.86 |
Common Stock | Stock Option (right to buy) | Disposition | 2019-08-12 | 5,000 | $0.00 | 5,000 | $6.45 |
Common Stock | Stock Option (right to buy) | Disposition | 2019-08-12 | 1,563 | $0.00 | 1,563 | $5.43 |
Common Stock | Stock Option (right to buy) | Disposition | 2019-08-12 | 7,083 | $0.00 | 7,083 | $9.05 |
Common Stock | Stock Option (right to buy) | Disposition | 2019-08-12 | 4,406 | $0.00 | 4,406 | $5.98 |
Common Stock | Stock Option (right to buy) | Disposition | 2019-08-13 | 4,640 | $0.00 | 4,640 | $10.45 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
4,642 | 2024-09-15 | No | 4 | M | Direct | |
0 | 2025-03-01 | No | 4 | M | Direct | |
11,253 | 2026-02-28 | No | 4 | M | Direct | |
5,210 | 2026-03-14 | No | 4 | M | Direct | |
37,188 | 2027-03-02 | No | 4 | M | Direct | |
48,469 | 2028-03-01 | No | 4 | M | Direct | |
2 | 2024-09-15 | No | 4 | M | Direct |
Footnotes
- The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 3, 2019.
- Represents weighted average sales price. Sale prices for the transactions range from $25.12 to $25.94. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
- The option is fully vested.
- The option became exercisable as to 25% of the shares on March 1, 2017, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.
- The option became exercisable as to 25% of the shares on March 15, 2017, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.
- The option became exercisable as to 25% of the shares on March 3, 2018, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.
- The option became exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.